Delta-like 1-Lysine613 regulates notch signaling  by Zhang, Liguo et al.
Biochimica et Biophysica Acta 1813 (2011) 2036–2043
Contents lists available at SciVerse ScienceDirect
Biochimica et Biophysica Acta
j ourna l homepage: www.e lsev ie r .com/ locate /bbamcrDelta-like 1-Lysine613 regulates notch signaling
Liguo Zhang, Ryan C. Widau 1, B. Paul Herring, Patricia J. Gallagher ⁎
Department of Cellular & Integrative Physiology, Indiana University School of Medicine, Indianapolis, IN 46202, United StatesAbbreviations: Dll1, Delta-like 1; DSL, Delta/Serrate
cellular domain; Notch-ECD, Notch extracellular dom
Split 1; HEY1, Hairy/enhancer of split related with YRPW
sor of Hairless/Lag1; siRNA, silencing RNA; IP, immunop
HA, hemaglutinin; MesNa, 2-mercaptoethanesulfonic ac
⁎ Corresponding author at: Department of Cellular &
University School of Medicine, 635 Barnhill Drive, Indian
States. Tel.: +1 317 278 2146; fax: +1 317 274 3318.
E-mail address: pgallag@iupui.edu (P.J. Gallagher).
1 Current address: Pediatric Hematology/Oncology,
5121A, 900 E. 57th Street, Chicago, IL 60637, United Sta
0167-4889/$ – see front matter © 2011 Elsevier B.V. Al
doi:10.1016/j.bbamcr.2011.08.019a b s t r a c ta r t i c l e i n f oArticle history:
Received 11 December 2010
Received in revised form 25 August 2011
Accepted 26 August 2011
Available online 2 October 2011
Keywords:
Notch
Delta
Ubiquitin
Endocytosis
Recycling
Lipid raft microdomainDelta ligands are important for regulating Notch signaling through transcellular stimulation of Notch recep-
tors. The cytoplasmic tails of Delta ligands have multiple potential regulatory sites including several lysine
residues that are putative targets for ubiquitination by the E3 ubiquitin ligases, Mind Bomb and Neuralized.
To identify possible roles for speciﬁc lysine residues in the cytoplasmic tail of the Notch ligand Dll1 a muta-
tional and functional analysis was performed. Examination of a panel of individual or clustered lysine mu-
tants demonstrated that lysine 613 (K613) in the cytoplasmic tail of Dll1 is a key residue necessary for
transcellular activation of Notch signaling. Multi-ubiquitination of the Dll1 mutant Dll1-K613R was altered
compared to wild type Dll1, and the K613R mutation blocked the ability of Dll1 to interact with Notch1. Fi-
nally, mutation of K613 did not affect the stability of Dll1 or its ability to trafﬁc to recycle to the plasma mem-
brane, but did enhance the fraction associated with lipid rafts. Collectively these results suggest that the
transcellular defect in Notch signaling attributed to residue K613 in cytoplasmic tail of Dll1 may result
from altering its multi-ubiquitination and increasing its retention in lipid rafts./Lag2; Notch-ICD, Notch intra-
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The Notch signaling pathway plays important roles in specifying
cell fate during embryonic development and contributes to adult ho-
meostasis [1,2]. Notch signaling is activated by transcellular interac-
tion between ligands of the Delta/Serrate/Lag2 (DSL) family in
signal-sending cells with Notch receptors in signal-receiving cells.
Five DSL ligands have been identiﬁed in mammals including three
Delta-like proteins (Dll1, 3, and 4) and two Jagged (Jagged1 and Jag-
ged2) proteins [3,4]. Notch receptors appear on the plasma mem-
brane of cells as non-covalently bound heterodimers that are
generated from a 300 kDa precursor form by proteolytic cleavage
(S1) mediated by a furin-convertase in the trans-Golgi. The cleaved
Notch1 heterodimer is composed of a 120 kDa Notch intracellular do-
main (Notch-ICD) subunit bound to its 180 kDa Notch extracellular
domain subunit (Notch-ECD) [5–7]. In response to transcellular bind-
ing between Notch and a member of the DSL ligand family, a second
protease cleavage (S2) site is exposed and cleaved by a member ofthe ADAM (a disintegrin and metalloproteinase) protease family. A
third cleavage, (S3/S4) is mediated by the intramembrane aspartyl
protease, γ-secretase. The S3/S4 cleavage liberates the Notch-ICD
from the membrane and the ICD is trafﬁcked to the nucleus where
it associates with a family of DNA-binding proteins called CSL
(CBF1/RBPJ-k/Su (H) Lag) to form a transcriptional complex for acti-
vation of speciﬁc target genes [8]. In addition to transcellular activa-
tion of Notch by Delta ligands, studies have also shown that this
ligand can interact with Notch when co-expressed on the same cell
and inhibit Notch activity (cis-inhibition) [9–14]. Ubiquitination of
DSL ligands including Delta is important for endocytic internalization
and recycling to the plasma membrane and may have a role in activa-
tion of the ligands prior to Notch receptor binding [3,15–22].
Endocytic trafﬁcking of DSL ligands is promoted in response to
monoubiquitination of the cytoplasmic tail of the ligand by the ubi-
quitin ligases, Mind bomb (Mib) or Neuralized (Neur) [19,23–27]. En-
docytosis facilitated by Epsin proteins may target the ligand to a
speciﬁc endocytic compartment that is necessary for DSL ligands to
become signaling competent as Epsin mutants move efﬁciently to
the plasma membrane, but do not signal. The exact nature of this ac-
tivation mechanism is unknown but could involve post-translational
modiﬁcations to the extracellular domain of the ligand within the
compartment or possibly clustering of the ligands to enhance signal-
ing [18,28–30].
Ubiquitination of proteins is associated with many aspects of cell
signaling including protein trafﬁcking, endocytosis, protein interac-
tions, kinase activation and degradation [31–33]. Heuss et al. [18] re-
cently characterized a murine Dll1 in which all 17 lysine (K) residues
within the cytoplasmic tail were mutated to arginine (R) (Dll1-K17R)
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revealed that Dll1-K17R is efﬁciently endocytosed, but recycling,
trans-endocytosis of Notch extracellular domain (Notch-ECD), as
well as activation of Notch transcellular signaling are impaired. In ad-
dition, Heuss et al. [18] demonstrated wild type Dll1 was partially lo-
calized to lipid rafts while Dll1-K17R was excluded from these
microdomains, an observation that could account for its failure to ac-
tivate Notch signaling. Although these studies are elegant and infor-
mative, the results from an extensively mutated Dll1 ligand do not
address the importance of, or allow identiﬁcation of speciﬁc functions
that can be attributed to individual lysine residues. In the current
study a panel of mutant Dll1 molecules was examined to investigate
the role of speciﬁc conserved lysine (K) residues in the cytoplasmic
tail of Dll1 and their potential role in Notch signaling, ubiquitination,
endocytic recycling and Notch receptor binding. These studies identi-
ﬁed a single, conserved lysine (K) residue K613 that is important for
both cis- and trans-cellular interactions between Dll1 and Notch to fa-
cilitate Notch signaling.
2. Materials and methods
2.1. Materials
MG132, anti-Vinculin (1:1000; V4505), anti-Flag M2 (1:1000,
A2220), anti-Pan Cadherin antibodies (1:1000; C1821/CH-19), protein
A beads, proteinG beads and protease inhibitor cocktailwere purchased
from Sigma (St. Louis, MO). Anti-Delta (1:1000; H-265/SC9102), and
anti-Notch1 (1:1000; C-20/SC-6014; H-131/sc9170) were from Santa
Cruz (Santa Cruz, CA) and have been previously validated [34,35].
Anti-caveolin-1 (1:1000; 610406) was from BD Biosciences. Anti-β-
tubulin (1:500; MAB3408, clone KMX-1) was from Millipore. Absolute
QPCRMixes were from ABgene (Rockford, IL). Fugene 6 transfection re-
agent was purchased from Roche Diagnostics (Indianapolis, IN). Dhar-
maFect-1 siRNA transfection reagent was from Dharmacon (Lafayette,
CO). Notch1/Fc chimera was from R&D (5267-TK) and comprises resi-
dues 19–526 from Notch1 fused to the Fc region of human IgG1.
2.2. Plasmids
The construction of full-length p3xFlag-MIB1 has been described
previously [36,37]. Mouse pYX-Asc-Dll1 was purchased from ATCC
(Manassas, VA), and pCDNA3-Dll1 was generated by PCR cloning of
the coding region of Dll1 into pcDNA3 (Invitrogen). The PCR generat-
ed cDNA was sequenced to conﬁrm the ﬁdelity of the reaction and no
alterations were identiﬁed. The Dll1 lysine mutant constructs were
made using site-directed mutagenesis (Stratagene) with mutated ol-
igonucleotide primers corresponding to mutation sites. All mutants
were conﬁrmed by sequencing. Vectors for expression of the hema-
glutinin-tagged (HA) ubiquitin were kindly provided by Dr. Ted Daw-
son (Johns Hopkins University). The pGL2-HES1 AB reporter and full
length Notch1 constructs were kindly provided by Dr. Nadia Carlesso
(Indiana University).
2.3. Cell culture and transient transfection
Wild type mouse embryo ﬁbroblast (MEF) cells were kindly pro-
vided by Dr. Maureen A. Harrington (Indiana University School of
Medicine, Indianapolis, IN). Human embryonic kidney HEK293 cells
(MPBiomedicals) and C3H10T1/2 (10T1/2) cells (ATCC, American
Type Culture Collection) were cultured in Dulbecco's modiﬁed Eagle's
medium supplemented with 10% fetal bovine serum. Transient trans-
fection of HEK293 cells was carried out using equal amounts of total
plasmid DNA (adjusted with the corresponding empty vectors) and
Fugene-6 transfection reagent according to the manufacturer's
guidelines.2.4. Western blotting, immunoprecipitation and lipid raft fractionation
Western blotting and immunoprecipitation were performed as
described previously using 7.5% SDS-PAGE [36]. Immunoreactive pro-
teins on Western blots were visualized using the Supersignal West
Pico or West Femto detection systems (Pierce) according to manufac-
turer's directions. All antibodies were used at a 1:1000 dilution for
western blotting except where noted. Cell extracts were prepared in
RIPA lysis buffer containing 0.1% Nonidet P-40, 1% sodium deoxycho-
late, 0.1% SDS, 0.15 M NaCl, 10 mM sodium phosphate, pH 7.2, 2 mM
EDTA, 50 mM sodium ﬂuoride, protease inhibitor cocktail and phos-
phatase inhibitor cocktails. For immunoprecipitation cells were
washed with PBS and lysates were prepared in lysis buffer (50 mM
Tris–HCl, pH 7.4, 0.1% Nonidet P-40, 1% Triton X-100, 1 mM EGTA,
1 mM EDTA, 0.15 M NaCl) containing a protease inhibitor cocktail.
For each immunoprecipitation, clariﬁed cell lysates were incubated
with anti-Delta, anti-Flag, anti-HA or IgG (control) antibodies at 4 °C
for at least 3 h. For immunoprecipitations, antibodies were diluted
1:100 in cell lysates containing equivalent amounts of total protein.
Protein A or protein G beads were added to the lysates and incubated
for further 1.5 h. Immune pellets were washed four times with lysis
buffer containing protease inhibitor cocktail, and precipitated pro-
teins were resolved by electrophoresis and then analyzed by Western
blotting. Western blotting was quantiﬁed using Fuji Imager software
(FUJI Medical Systems, USA). Lipid raft fractionation was performed
as described by Heuss et al. [18]. HEK293 cells were transfected
with plasmids encoding either wild type or K613R mutant Dll1. At
48 h post-transfection, the cells were lysed in 2 mL TN buffer
(20 mM Tris, pH7.5; 150 mM NaCl) containing 1% Brij 98 for 30 min
on ice. Following passage through a 25-G needle 15 times, the lysates
were adjusted to a ﬁnal concentration of 40% sucrose/1% Brij 98 in TN
buffer. Gradients were assembled by the addition of 4 mL of 30% and
4 mL of 5% sucrose in TN buffer. Following centrifugation for 20 h at
230,000×g, 1 mL fractions were collected from the top to the bottom
of the gradient and 40 μL of each fraction was analyzed by western
blotting using anti-Delta, anti-β-tubulin and anti-caveolin-1 to iden-
tify lipid raft and cytoplasmic fractions.
2.5. Immunoprecipitation of Dll1 from intact cells with N1-Fc
HEK293 cells transiently transfected with vectors for expression of
Dll1 were scraped and collected. The cells were washed three times in
PBS containing 0.1 mM CaCl2. The washed cells were then incubated
in PBS/0.1 mM CaCl2 with 1 μg/mL recombinant Notch1-Fc fusion
protein for 18 h at 4 °C and then washed three times in PBS/CaCl2 to
remove unbound Notch1-Fc before addition of lysis buffer. Equal
amounts of lysate were incubated overnight with 50 μL 10% protein
G beads to fractionate the Notch1-Fc/Dll1 complexes.
2.6. In vivo ubiquitination
HEK293 cells were transiently transfectedwith Dll1 or HA-Ubiquitin
constructs as indicated. After 24 h, the transfected cells were treated
with MG132 for a further 16 h. Cell lysates were prepared in RIPA
lysis buffer with protease inhibitor cocktail and MG132 (10 μM). Ubi-
quitinated proteins were immunoprecipitated from the cell extract
using anti-HA antibodies andwestern blotting was performed to detect
the presence of Dll1.
2.7. Quantative RT-PCR (qRT-PCR) analysis of mRNA
RNA was extracted with TRIzol reagent (Invitrogen). 1.2 μg of RNA
was used as template for reverse transcription (RT) using Superscript
ﬁrst strand cDNA synthesis kit (Invitrogen) and the resulting cDNAs
were dissolved in 20 μL H20. The cDNA levels of speciﬁc genes were
measured by quantitative real time PCR using Absolute QPCR Mixes
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tems). The gene- and mouse-speciﬁc primers used for QPCR are
mHPRT1 5′-GTT ATT GGT GGA GAT GAT CTC TCA ACT-3′ and 5′-
TGC AAC CTT AAC CAT TTT GGG GCT G-3′, mHES1 5′-GCT AGA GAA
GGC AGA CAT TCT GGA AAT GA-3′ and 5′-CGC GGT ATT TCC CCA
ACA CGC T-3′, mHEY1 5′-TCC CTG CTT CTC AAA GGC ACT-3′ and 5′-
GGA AAA GAC GGA GAG GCA TCA-3′, mHEY2 5′-AAG CGC CCT TGT
GAG GAA A-3′ and 5′-TGT CGG TGA ATT GGA CCT CAT-3′. All samples
were ampliﬁed in duplicate and every experiment was repeated at
least 2 times using biologically independent samples. Relative gene
expression was converted using the 2−ΔΔCt method against the inter-
nal control HPRT1 housekeeping gene.
2.8. Reporter gene assays
Reporter plasmid transfection was carried out using FuGENE6
transfection reagent (Roche) according to the manufacturer's guide-
lines. The level of promoter activity was evaluated by measurement
of the ﬁreﬂy luciferase activity relative to the internal control TK-
Renilla luciferase activity using the Dual Luciferase Assay System es-
sentially as described by the manufacturer (Promega). A minimum
of six independent transfections was performed and all assays were
performed in duplicate. Results are reported as the mean±S.E.
2.9. Endocytosis assay
Endocytosed and exocytosed recycled proteins were identiﬁed
using a reversible biotinylation assay as previously described [38]
with minor modiﬁcations (see Supplemental Fig. S2 for details).
2.10. Statistical analysis
Results are expressed as mean±S.D. The Student's t test was used
to compare quantitative data where indicated. A value of pb0.05 was
considered statistically signiﬁcant.
3. Results
3.1. K613 in the cytoplasmic tail of Dll1 is required for Notch signaling
To identify potential conserved ubiquitination sites within the cy-
toplasmic tail of Dll1, the sequences of the intracellular domains of
DLL frommouse, human and rat were aligned and examined (Supple-
mental Fig. S1). This analysis identiﬁed ﬁfteen highly conserved K
sites in the cytoplasmic domain of Dll1. A previous study [18] gener-
ated a single mutant Dll1 having 17 K residues within the cytoplasmic
tail altered to R. Although the complete sequence of the cDNA used in
this previous study was not included, the sequence encompassing the
speciﬁc lysine residues that were mutated was noted. A comparison
of the K residues in the previous report and those in our clone and
clones from the GenBank database revealed that residue 628 which
is K in the Heuss et al. [18] Dll1 clone is a highly conserved acidic res-
idue in the mouse clone used for our study as well as rat and human
Dll1 clones. In addition, residue 572 is a K residue in both mouse and
rat Dll1 clones, but is R in human clones and this residue as well as
residue E628 were not targeted for mutation in the mouse Dll1 used
in the current study.
To determine which of these ﬁfteen K residues in the cytoplasmic
tail of mouse Dll1 has a role in regulating Notch signaling, a series of
Dll1 mutants was generated in which each of these K residues was
replaced by arginine (R) either singularly (K575R, K600R, K613R,
K617R, K618R, K648R, K675R, K689R, K699R, K702R, K713R) or in
combination when conserved K residues were clustered together
(K613–618R, K660–664R, K629–633R). The effects of the mutant K
to R mouse Dll1 proteins on Notch transcellular signaling were deter-
mined using a transcellular co-culture assay. Plasmids encodingmurine Dll1 were transfected into human HEK293 cells and after
24 h the transfected HEK293 cells were co-cultured with multi-po-
tent mouse 10T1/2 cells or primary mouse embryo ﬁbroblasts,
which both express Notch1 receptors on their plasma membranes
[39–41]. Using mouse speciﬁc primers, qRT-PCR was used to monitor
the expression of Notch target genes: HES1, HEY1 and HEY2. Of elev-
en Dll1 mutants initially tested, only the triple mutant K613R–K618R
resulted in a highly signiﬁcant decrease (pb0.001) in expression of
the Notch target genes compared to the wild type Dll1 in 10T1/2
cells (Fig. 1A). Expression of three other mutants (Dll1-K689R,
-K699R and -K713R) also resulted in attenuated expression of the
Notch target genes, although the magnitude of this reduction was
smaller and had lower signiﬁcance (pb0.05). To determine if all
three K residues in the triple mutant Dll1-K613-618R were important
for expression of Notch target genes, three single mutants were gen-
erated using site-directed mutagenesis (Dll1-K613R, -K617R and
-K618R). Analysis of these three single mutants using the same
HEK293 co-culture approach with 10T1/2 cells (Fig. 1B) or with
mouse embryo ﬁbroblasts (MEFs) (Fig. 1C) revealed only the triple
mutant, Dll1-K613-168R and the single mutant, Dll1-K613R were sig-
niﬁcantly (pb0.001) defective in their ability to activate HES1, HEY1,
and HEY2. Finally, activation of a HES1 luciferase reporter plasmid in
10T1/2 cells was signiﬁcantly attenuated (pb0.001) when co-cul-
tured with HEK293 cells expressing Dll1K613-618R or -K613R as
compared to HEK cells expressing wild type Dll1 (Fig. 1D). We also
observed a small although signiﬁcant (pb0.05) attenuation in HES1
reporter activity with many of the other K mutant DLL1 molecules
(Fig. 1D). These data clearly suggest that residue K613 in the cyto-
plasmic tail of Dll1 is the most important lysine for the transcriptional
activation of Notch target genes in a transcellular co-culture assay.
3.2. Ubiquitination of Dll1-K613R is altered
As the results in Fig. 1 suggested that Dll1-K613 was important for
transcriptional activation of several Notch1 genes, the ubiquitination
proﬁle of the Dll1-K613-617R and Dll1-K613R mutants was com-
pared to wild type Dll1 as well as the remaining panel of mutant
Dll1 molecules (Fig. 2). Lysates from HEK293 cells transfected with
vectors for expression of either with wild type or mutant Dll1, HA-
ubiquitin, and Mib1 were examined by western blotting to detect
Dll1 in total ubiquitinated protein fractions. This analysis revealed
that the ubiquitination proﬁle of Dll1-K613-617R and Dll1-K613R
was altered compared to the wild type Dll1 and the remaining Dll1
mutants. Speciﬁcally it was noted that only a single mono-ubiquiti-
nated species was detected and the typical ubiquitin ladder that is
found in the remaining Dll1 mutants was strongly attenuated.
3.3. Dll1-K613R interacts with Mib1
To determine whether or not the attenuated ubiquitination of
Dll1-K613-618R or K613R resulted from altered binding between
the ubiquitin ligase Mib1 and the mutant Dll1 proteins, HEK293
cells were transfected with plasmids for expression of ﬂag tagged
Mib1 and Dll1 wild type or mutants as indicated (Fig. 3). After 24 h,
the cells were lysed and Mib1 was immunoprecipitated using anti-
Flag antibody. The immune complexes were then analyzed by west-
ern blotting to determine if Dll1 was present (Fig. 3). The results of
this co-immunoprecipitation experiment demonstrated that both
Dll1-K613-618R and Dll1-K613R mutants interact with Mib1 similar
to wild type Dll1.
3.4. Residue K613 in Dll1 is important for interaction with Notch1 extra-
cellular domain
A key step in the activation of Notch target genes and inhibition of
Notch signaling is physical interaction between Dll1 ligands and Notch
Fig. 1. K613 in the cytoplasmic tail of Dll1 is required for Notch signaling. A–C, HEK293 cells were transfected with wild type Dll1 (WT) or the indicated Dll1 mutants and after 24 h,
the HEK293 cells were co-cultured with 10T1/2 cells (A–B) or MEF cells (C). After 36 h in co-culture, total RNA was prepared and qRT-PCR was carried out to detect the gene ex-
pression of mouse HES1, HEY1 and HEY2 using species-speciﬁc primers. Samples were ampliﬁed in duplicate and each experiment was repeated at least 2–3 times on independent
samples, (*pb0.05; **pb0.001) D, Luciferase promoter activation assays were performed using 10T1/2 cells that had been transfected with a luciferase HES1 reporter plasmid for
12 h before co-culture with HEK293 cells transfected with wild type or the indicated Dll1 mutants. Cell lysates were prepared and luciferase activity was measured as described in
Materials and methods section. Luciferase values are presented as relative luciferase activity compared to empty expression vectorwhichwas normalized to 1 and are themean±S.E. of 6
samples, *pb0.05; **pb0.001. Statistical signiﬁcance was determined by the Student'st test.
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ing between Notch1 andDll1 or Dll1-K613Rwas altered, the association
of these molecules was examined using puriﬁed, recombinant Notch1/
Fc to immunoprecipitate Dll1 both in cis (from lysed cells) and trans
(from intact cells) conﬁgurations. Notch1/Fc is a chimeric fusion proteincomprised of Notch1-ECD (residues 19–526) fused to Fc region of
human IgG and can be used as a source of Notch1-ECD. To determine
if cis bindingbetweenNotch andDll1 is altered, HEK293 cells transiently
expressing eitherwild type ormutant Dll1were lysed and the cell lysate
was then incubated with puriﬁed, recombinant Notch1/Fc (Fig. 4A).
Fig. 2. Ubiquitination of Dll1 K613 is altered. HEK293 cells were transfected with HA-
ubiquitin, Mib1, and wild type or mutant Dll1 as indicated. At 24 h the cells were trea-
ted with 10 μM MG132 for an additional 16 h to allow accumulation of ubiquitinated
proteins before lysis. HA-tagged ubiquitinated proteins were immunoprecipitated
using anti-HA antibody and Dll1 was detected by western blotting using anti-Delta an-
tibody (sc-9102). To conﬁrm the presence of the relevant proteins, an aliquot represent-
ing 1/20th of the total cell extract (CE) was reserved prior to immunoprecipitation and
analyzed in parallel for expression of Dll1 (lower panel). A representative blot is
shown, n=3. IP, immunoprecipitation; WB, western blotting; Ub, ubiquitin; WT, wild
type.
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that only wild type Dll1 or the mutants K617R and K618R Dll1 bound
Notch1/Fc while K613–618R or K613R did not (Fig. 4A). These data sug-
gest that cis interactions between Notch and the mutant Dll1-K613-
618R or Dll1-K613R are signiﬁcantly impaired compared to wild type
Dll1. To determine if trans binding between Notch and Dll1 is also al-
tered, Notch1/Fc was incubatedwith intact cells and then the remaining
unbound Notch1/Fc waswashed before cell lysis and addition of protein
G (Fig. 4B). Dll1-K613R was not present in Notch1/Fc immune com-
plexes from intact cells (Fig. 4B) suggesting that trans interactions be-
tween Notch and the Dll1-K613R mutant are attenuated. Western
blotting of input cell extracts conﬁrmed the presence of Dll1 and
Notch1/Fc in cell lysates. These results demonstrate the importance of
K613 in Dll1 for binding to the Notch1-ECD fusion protein both in
whole cell lysates (cis) and to Dll1 on the surface of intact cells (trans).
3.5. Mutation of Dll1 K613 does not alter its membrane endocytosis or
recycling, but does alter lipid raft localization
Previously, a Dll1 mutant that was unable to be ubiquitinylated
was shown to be trafﬁcked to the plasma membrane efﬁciently, but
to be defective in membrane recycling and excluded from lipid raft
microdomains [18]. Based on this, we sought to determine if Dll1-Fig. 3. Dll1-K613R interacts with Mib1. HEK293 cells were co-transfected with Mib1
and either DLL1-WT, DLL1-K613-618R, or DLL1-K613R plasmids as indicated. After
36 h, Mib1 was immunoprecipitated using anti-Flag antibody. Western blots were
probed with anti-Flag or anti-Delta (sc-9102) antibodies to detect Mib1 or DLL1.
Shown is a representative blot, n=3. IP, immunoprecipitation; WB, western blotting;
CE, cell extract; WT, wild type.K613R alters trafﬁcking to and from the plasma membrane using an
assay to measure the apparent rate of trafﬁcking of the wild type
(WT) and mutant Dll1-K613R to the plasma membrane [38]. In this
assay the relative changes in the internalized, biotin-labeled pool of
Dll1 following incubation periods at either 4 °C (no recycling) or
37 °C (recycling) were determined (see Materials and methods sec-
tion and Supplemental Fig. S2A for details). Preliminary experiments
using intact HEK293 cells established that within 30 min at 37 °C, bio-
tinylation of Dll1 is maximal and that MesNa treatment was able to
effectively strip biotin from labeled surface proteins (Supplemental
Fig. S2B,C). To determine the changes in the relative level of the inter-
nal, biotinylated pools of Dll1 as an indicator of the rate of endocyto-
sis, wild type Dll1-WT or mutant Dll1-K613R were expressed in
HEK293 cells and the surface membrane proteins of intact cells
were biotinylated for 30 min at 37 °C to allow for cycling and maxi-
mal labeling of the various pools of membrane proteins. Biotinylated
proteins were puriﬁed using streptavidin conjugated beads and ana-
lyzed by western blotting. For all the blots in Fig. 5A, the intensity of
the Dll1 bands in lanes 2–6 was ﬁrst normalized to the total Dll1
shown in the CE blot and then compared to the biotinylated Dll1 pre-
sent in the streptavidin fraction following the labeling period (Fig. 5A,
lane 1). To determine the fraction of the total biotinylated pool that
was located in an internal compartment, the labeled cells were incu-
bated at 4 °C to block further endocytic recycling and MesNa was
used to strip the biotin from the exposed plasma membrane proteins
(MesNa1) before cell lysis. This leaves only the internalized Dll1 la-
beled with biotin (Fig. 5A, lane 2). Cells were then returned to 37 °C
for either 15 or 30 min to allow the internalized biotinylated Dll1 to
recycle back to the plasma membrane or to be degraded (Fig. 5A,
lanes 3,5). In parallel, cells were subjected to a second round of strip-
ping (MesNa2) following this 37 °C incubation to remove the labeled
Dll1 that had recycled to the plasma membrane (Fig. 5A, lanes 4,6).
The decreased Dll1 signal seen between lanes 3 and 4 and between
lanes 5 and 6 thus represents that amount of biotinylated Dll1 that
had recycled back to the plasma membrane during the 15 or 30 min
incubation at 37 °C, respectively. The signals on the western blots
(obtained from 3 separate experiments) were quantitated by densi-
tometry and compared to the total biotinylated Dll1 (lane 1) and
the percent Dll1 remaining in the biotinylated fraction is shown in
the table (Fig. 5B).
Approximately 57.8±5.3 and 58.5±4.1% of the pool of biotiny-
lated wild type or mutant Dll1 respectively was sequestered in an in-
ternal compartment following labeling (0 min at 37 °C). The amount
of the internalized biotinylated Dll1 that recycled back to the plasma
membrane after 15 or 30 min incubation at 37 °C was similar for
both wild type and K613R mutant Dll1. At 15 min 27.5±3.5% of the
wild type and 27.2±2.7% of the mutant remained in the internal
compartment (Fig. 5A) and after 30 min 14.2±3.1% of the wild type
and 11.4±2.6% of the mutant remained in the internal compartment.
During this recycling period it was also noted that there was a signif-
icant decrease in the total biotinylated wild type (57.8 vs. 36.5%) and
mutant Dll1 (58.5 vs. 33.5%) following 30 min of incubation at 37 °C
(Fig. 5A,B lanes 2 and 5). This decrease likely represents degradation
of Dll1 during the experiment. The decrease determined for
both wild type and K613R is not statistically signiﬁcant (36.5±2.4
vs. 33±3.9%; Fig. 5A,B, lane 5), suggesting that K613R is not degraded
more rapidly than wild type Dll1. In control experiments, the levels of
the internal pool of biotinylated cadherins detected by a pan-cad-
herin antibody also remained relatively stable during this period
(32.8±3.2 vs. 30.8±2.5%; Fig. 5A,B, lanes 2 and 5). Together, these
results suggest that mutation of K613 in Dll1 does not signiﬁcantly
alter the rate of its cycling between the plasma membrane and inter-
nal compartments or its stability compared to wild type Dll1.
To determine if mutation of residue K613 alters lipid raft microdo-
main localization, the fraction of Dll1 WT or K613R localized to caveo-
lin-1 containing membrane fractions was determined (Fig. 5C).
Fig. 4. Residue K613 in Dll1 is important for both cis and trans interactions with Notch1. A, HEK293 cells were transfected with wild type or mutant Dll1 as indicated. After 36 h cell
lysates were prepared and then incubated with 1 μg/mL recombinant Notch1-Fc fusion protein pre-complexed to protein G agarose. Western blotting was carried out to detect Dll1
and Notch1-Fc using anti-Delta (sc-9102) or anti-Notch1 (sc-9170) antibodies. To conﬁrm the expression of proteins western blotting of 25 μg total cell extract was used. B, HEK293
cells were transfected with wild type or mutant Dll1 as indicated. After 36 h, the intact cells were incubated with 1 μg/mL recombinant Notch1-Fc fusion protein for 18 h at 4 °C, the
intact cells were washed to remove unbound Notch1-Fc, lysed and then equal amounts of total protein were incubated with protein G agarose. To conﬁrm the presence of the rel-
evant proteins, an aliquot representing 25 μg of the total cell extract (CE) was reserved prior to immunoprecipitation and analyzed in parallel. Western blotting was carried out as in
‘A’ and vinculin was used to conﬁrm that equivalent amounts of CE were used for analysis. Representative blots are shown for each panel; n=3. IP, immunoprecipitation, CE, cell
extract, N1-Fc, Notch1 extracellular domain-Fc fusion protein.
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or K613R mutant Dll1 and fractionated on sucrose density gradients
[18]. Membrane fractions were analyzed by western blotting to deter-
mine howmuch Dll1 was present in the caveolin-1 rich lipid raft frac-
tions. As expected, caveolin (24 kDa) was restricted to fractions
located at the top of the gradient. There was some small experimental
variation in the number of fractions in which caveolin was readily de-
tectable ranging from fractions 1–3 to fractions 1–5, likely reﬂecting
small differences in the preparation and collection of the gradient
and the total amount of protein loaded. Densitometric analysis com-
paring the amounts of Dll1 WT or K613R in caveolin-1 containing
fractions revealed that there was a signiﬁcant difference in their dis-
tribution. This analysis showed that 25.9±3.0% of Dll1 WT compared
to 37.5±2.6% of K613R is in caveolin-1 containing fractions. These re-
sults suggest that Dll1-K613R is more efﬁciently recruited to lipid
rafts or alternatively, is less effectively endocytosed from lipid rafts.
4. Discussion
These studies demonstrate that residue K613 in the cytoplasmic
tail of Dll1 is critically important for activation of Notch signaling.
Mutation of Dll1-K613 to R attenuated transcellular Notch1 signaling
and activation of target genes in co-cultured cells. The ubiquitin pro-
ﬁle of this mutant is altered such that multi-ubiquitination is greatlyattenuated, despite the fact that Dll1-K613R interacts with at least
one E3 ubiquitin ligase, Mib1. Dll1-K613R is also unable to physically
interact with Notch1 receptors either in cis or trans conﬁgurations, al-
though it is expressed at the cell surface, endocytosed and degraded
at a similar rate to wild type Dll1. Interestingly, there is a higher
level of Dll1-K613R present in lipid raft microdomains, suggesting
that this mutation may alter endocytosis from rafts or alternatively
enhance association with these microdomains.
Several possible mechanisms could explain howmutation of K613
within the cytoplasmic tail of Dll1 profoundly reduces the activation
of Notch dependent genes. These include alteration to ubiquitination,
trafﬁcking to and from the membrane, inability to interact with Notch
receptors or ubiquitin ligases, and stability or degradation. Examina-
tion of each of these possibilities led to the discovery that Dll1-
K613R has an altered pattern of ubiquitination and an impaired abil-
ity to interact with Notch receptors (Figs. 2 and 4). In contrast, Dll1-
K613R interacted with at least one ubiquitin ligase Mib1, (Fig. 3),
and was localized to the plasma membrane and underwent mem-
brane recycling (Fig. 5) similar to wild type Dll1.
The ﬁnding that global recycling and stability of Dll1-K613R is not
signiﬁcantly different towild type led to the examination of the fraction
of thismutant present in lipid raftmicrodomains. Interestingly, the frac-
tion of Dll1-K613R present in these microdomains is greater than wild
type Dll1. This result can be interpreted in at least two ways, which
Fig. 5.Mutation of Dll1 K613 does not alter membrane endocytosis or recycling, but does alter lipid raft localization. A, HEK293 cells were transfected with plasmids for expression
ofwild type (WT) ormutant Dll1-K613R as indicated, and the trafﬁcking of Dll1 between internal compartments and the plasmamembranewas determined as described inMaterials
and methods section and Supplementary Fig. S2. The biotinylated Dll1 in streptavidin fractions was detected using anti-Delta antibodies (sc-9102). Cadherins are known to undergo
endocytosis and recycling and serve as a control. Cadherins were detected using an anti-Pan-cadherin antibody (CH-19). Shown are representative blots, n=3. CE, cell extract, rep-
resents 1/20th of the total cell extract prior to streptavidin fractionation; WB, western blot. B, Data shown in ‘A’were quantitated from 3 separate experiments, and the percent ±SD
(%) of biotinylated Dll1 present in each groupwas shown. These values were determined by ﬁrst normalizing the biotinylated Dll1 in the streptavidin fraction to the amount of Dll1 in
the corresponding CE lane and then comparing this value to total biotinylated Dll1 (lane 1). C, Western blotting of HEK293 cells transfected with either wild type (WT) or K613R
mutant Dll1. At 40 post-transfection, cells were mechanically lysed in buffer containing 1% Brij98 and then fractionated by ultracentrifugation through a sucrose step-gradient as
described in Materials and methods section. Fractions were collected from top (fraction 1) to the bottom (fraction 12) of the gradient. Antibodies to β-tubulin (55 kDa), or caveo-
lin-1 (24 kDa) were used to deﬁne cytoplasmic (detergent soluble) or lipid raft (detergent insoluble) fractions respectively, in the gradient. Bands were quantitated by densitometry
and the percentage of Dll1 present in the caveolin positive fractions was determined. Mean data±SD obtained from 3 to 4 independent experiments are shown in the graph. ** in-
dicates statistical signiﬁcance; pb0.05, Students t test.Mutation of Dll1 K613 does not alter membrane endocytosis or recycling, but does alter lipid raft localization. A, HEK293 cells
were transfectedwith plasmids for expression of wild type (WT) ormutant Dll1-K613R as indicated, and the trafﬁcking of Dll1 between internal compartments and the plasmamem-
brane was determined as described in Materials and methods section and Supplementary Fig. S2. The biotinylated Dll1 in streptavidin fractions was detected using anti-Delta anti-
bodies (sc-9102). Cadherins are known to undergo endocytosis and recycling and serve as a control. Cadherins were detected using an anti-Pan-cadherin antibody (CH-19). Shown
are representative blots, n=3. CE, cell extract, represents 1/20th of the total cell extract prior to streptavidin fractionation; WB, western blot. B, Data shown in ‘A’ were quantitated
from 3 separate experiments, and the percent±SD (%) of biotinylated Dll1 present in each groupwas shown. These values were determined by ﬁrst normalizing the biotinylated Dll1
in the streptavidin fraction to the amount of Dll1 in the corresponding CE lane and then comparing this value to total biotinylated Dll1 (lane 1). C, Western blotting of HEK293 cells
transfected with either wild type (WT) or K613R mutant Dll1. At 40 post-transfection, cells were mechanically lysed in buffer containing 1% Brij98 and then fractionated by ultra-
centrifugation through a sucrose step-gradient as described in Materials and methods section. Fractions were collected from top (fraction 1) to the bottom (fraction 12) of the gra-
dient. Antibodies to β-tubulin (55 kDa), or caveolin-1 (24 kDa) were used to deﬁne cytoplasmic (detergent soluble) or lipid raft (detergent insoluble) fractions respectively, in the
gradient. Bands were quantitated by densitometry and the percentage of Dll1 present in the caveolin positive fractions was determined. Mean data±SD obtained from 3 to 4 inde-
pendent experiments are shown in the graph. ** indicates statistical signiﬁcance; pb0.05, Students t test.
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K613R to lipid microdomain is enhanced because of structural differ-
ences related to either the residue change or altered ubiquitination. If
indeed structural alterations are responsible, they are likely subtle as
the degradation of thismutant is similar towild type Dll1. Alternatively,
it is possible that endocytosis from lipid rafts is attenuated, even though
global endocytosis of Dll1-K613R is not signiﬁcantly different fromwild
type Dll1. This may suggest that recycling from lipid microdomains is a
key event in “activation” of Dll1 ligand to a state competent to interact
with Notch receptor. Although the steps leading to “activation” of DSL
ligands are poorly understood, endocytosis is thought to be important
for generation of an “active” ligand that is competent for a productive
interaction with Notch receptors to initiate signaling [18,43,44]. The
current studies further reﬁne this paradigm, suggesting the possibility
that endocytic recycling from lipid microdomains is a key event to li-
gand activation.
Comparison of the ubiquitination pattern of wild type Dll1 to the
panel of Dll1 mutants revealed that they all appear to be mono-ubi-
quitinated, as evidenced by the prominent ubiquitin band detectedby anti-Dll1 antibody in the ubiquitinated fraction of cellular proteins.
At least 2–3 additional ubiquitinated forms are also consistently evi-
dent in this panel of mutants resembling a ladder of multi-ubiquiti-
nated Dll1 species. The only exception to this ubiquitination pattern
in this panel of conserved K mutants is Dll1-K613, which lacks this
laddering pattern, although it does appear to be mono-ubiquitinated.
This ﬁnding raises the possibility that loss of one ubiquitination site
promotes ubiquitination of one of the other K residue(s) in the cyto-
plasmic tail of Dll1 and could account for the failure to identify a dom-
inant ubiquitination site. It is also possible that K572 in mouse and rat
Dll1, which is not conserved in human sequences and therefore was
not analyzed in our study, could be an important murine speciﬁc ubi-
quitination site. However, as there are no other non-conserved K res-
idues in the human Dll1 cytoplasmic tail that could correspond to
mouse K572, it is difﬁcult to see how the additional K at position
572 in mice and rats can be of major physiological importance.
The ﬁndings of the current study, complement and extend those of
Heuss et al. [18]. In this previous study, all of the K residues in the in-
tracellular domain of a mouse Dll1 were mutated to R to generate a
2043L. Zhang et al. / Biochimica et Biophysica Acta 1813 (2011) 2036–2043“ubiquitin-less”mutant (K17R). The K17Rmutant exhibited a complete
lack of ubiquitination, did not activate Notch signaling, and although
thismutantwas endocytosed, its endocytic recycling back to the plasma
membrane was severely attenuated. In contrast to the current results,
the ubiquitinless K17R mutant was completely excluded from lipid
raft microdomains. These previous results suggested the possibility
that ligand recycling and lipid raft localization of Dll1 are both required
for activation of Notch signaling [19]. The current studies demonstrate
that someof the defects observed in the K17RmutantDll1 are separable
and can be attributed to functions of different lysine residueswithin the
Dll1 cytoplasmic tail. For example, K613 is critical for Notch signaling,
and its mutation results in a loss of the observed multi-ubiquitination
of Dll1, but does not alter the endocytic recycling of Dll1-K613R to the
plasma membrane or its stability and increases its association with
lipid raft microdomains. In addition, it appears that endocytic recycling
and notch binding can be separated based on the ﬁnding that Dll1-
K613R is recycled as efﬁciently aswild type Dll1 but is unable to interact
with and signal to Notch receptors.
5. Conclusion
Collectively, the results of the current studies demonstrate that
residue K613 on the cytoplasmic tail of Dll1 is required for both cis
and transcellular interactions between Dll1 and Notch1 receptors, as
well as for activation of Notch signaling. Although the endocytic recy-
cling and stability of Dll1-K613R is not altered, its localization to lipid
raft microdomains is enhanced. Dll1-K613R binds Mib1 and although
it is still mono-ubiquitinated, the typical multi-ubiquitination pattern
is reduced. These studies identify K613 of Dll1 as a key focal point for
regulating Notch signaling and endocytic activation of Notch ligands.
Supplementary materials related to this article can be found on-
line at doi:10.1016/j.bbamcr.2011.08.019.
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